Nervous System Diseases: Neurogenic faecal incontinence Nervous System Diseases Neurogenic faecal incontinence
Conditions
Interventions
Patients randomised to 1 of 3 groups, all will receive current biofeedback therapy, but at different time intervals:
1. Group 1 - Behaviour Modification - Baseline TMS - Behaviour Modification - TMS -
Sponsors
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 30 Patients over the age of 18 with neurogenic faecal incontinence will be recruited from the referrals to Mr ES Kiff and 15 controls.
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To establish any cortical neuroplastic changes or nerve conduction changes in response to current treatments for faecal incontinence. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed